GSK to launch Phase 3 test of mRNA flu vaccine with newer formulation

GSK on Tuesday said it will start a late-stage trial of its mRNA vaccine for seasonal influenza after the candidate delivered “higher immune responses” than traditional vaccines in a Phase 2 test. The UK pharma ...